Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.

In a prospective, randomized trial, norfloxacin (400 mg perorally, twice a day) was compared with trimethoprim-sulfamethoxazole (160-800 mg perorally, twice a day) in 45 patients with uncomplicated urinary tract infections. Escherichia coli was the most common isolate. Infections due to Enterobacter...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Goldstein, E J, Alpert, M L, Ginsberg, B P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176290/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3158277/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.3.422
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!